Tasigna (nilotinib) is a powerful drug used to treat chronic myeloid leukemia. Tasigna works by blocking certain proteins, thereby preventing cancer cell growth in patients. New lawsuits point to a connection between Tasigna and the deadly condition of atherosclerosis, which causes plaque to build up in arteries.
Tasigna, also know in it’s generic form as nilotinib, is used to treat patients suffering from Philadelphia chromosome-positive chronic myelogenous leukemia (CML), a condition that affects the body’s white blood cells. If you are experience complication due to tasigna drug then you can contact Tasigna Lawyer for filing Tasigna Lawsuit.
An ailment of the supply routes, atherosclerosis causes plaque development inside the conduits, narrowing the way of blood stream and bringing about decreases in oxygen-rich blood to the heart and all through the body.
At the point when plaque develops, bits of plaque can sever and are conveyed by the circulation system to different parts of the body causing blockages and complexities. Some reactions of atherosclerosis are heart assault, stroke, coronary illness, chest torment, fringe supply route ailment, appendage removal, and demise.
The main Tasigna wrongful passing claim was documented against Novartis in 2016 by the surviving relatives of Dainis Lauris. Mr. Lauris took Tasigna starting in 2012 and proceeded with it for a little more than a year prior to his femoral vein shut off totally because of atherosclerosis. He likewise endured a 40-60% narrowing of the coronary conduits, and a 70% narrowing of his cerebral corridors.
If you or a family member has taken Tasigna and developed atherosclerosis or other vascular diseases, you may be entitled to compensation from the manufacturer for your injuries.